Gao X, Yang ZH, Cheng YH, Chi CL, et al. Treatment burden and cost-effectiveness analysis of the neoadjuvant CROSS regimen in esophageal squamous cell carcinoma: a multicenter retrospective study. Dis Esophagus 2023 May 26:doad031. doi: 10.1093.
PMID: 37236810